Our study highlights the relevance of miRNAs as critical players in the pathogenesis of CLL and shows for the first time that miR-223 modulates HSP90B1 expression in B lymphocytes of CLL. The gene discussed is HSP90B1; the disease is B-cell chronic lymphocytic leukemia.